Joensuu H - Search Results

1

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES. Dores GM, et al. Among authors: joensuu h. Ann Oncol. 2014 Oct;25(10):2073-2079. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25. Ann Oncol. 2014. PMID: 25185241 Free PMC article.

2

Cured of breast cancer?

Joensuu H, Toikkanen S. Joensuu H, et al. J Clin Oncol. 1995 Jan;13(1):62-9. doi: 10.1200/JCO.1995.13.1.62. J Clin Oncol. 1995. PMID: 7799044

3

Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.

Joensuu H, Ristamäki R, Söderström KO, Jalkanen S. Joensuu H, et al. J Clin Oncol. 1994 Oct;12(10):2167-75. doi: 10.1200/JCO.1994.12.10.2167. J Clin Oncol. 1994. PMID: 7931487 Clinical Trial.

4

Does the month of diagnosis affect survival of cancer patients?

Sankila R, Joensuu H, Pukkala E, Toikkanen S. Sankila R, et al. Among authors: joensuu h. Br J Cancer. 1993 Apr;67(4):838-41. doi: 10.1038/bjc.1993.153. Br J Cancer. 1993. PMID: 8471442 Free PMC article.

5

Autologous stem cell transplantation in breast cancer.

Joensuu H. Joensuu H. Ann Med. 1996 Apr;28(2):145-9. doi: 10.3109/07853899609092939. Ann Med. 1996. PMID: 8732643 Review.

6

Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.

Villikka K, Muhonen T, Ristamäki R, Teerenhovi L, Joensuu H. Villikka K, et al. Among authors: joensuu h. Acta Oncol. 1997;36(6):619-24. doi: 10.3109/02841869709001325. Acta Oncol. 1997. PMID: 9408153 Clinical Trial.

7

Repopulation during radical radiotherapy for T1 glottic cancer.

Saarilahti K, Kajanti M, Lehtonen H, Hämäläinen T, Joensuu H. Saarilahti K, et al. Among authors: joensuu h. Radiother Oncol. 1998 May;47(2):155-9. doi: 10.1016/s0167-8140(97)00222-3. Radiother Oncol. 1998. PMID: 9683363

8

Second cancer among long-term survivors from Hodgkin's disease.

Nyandoto P, Muhonen T, Joensuu H. Nyandoto P, et al. Among authors: joensuu h. Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):373-8. doi: 10.1016/s0360-3016(98)00217-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9788418

9

Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.

Joensuu H, Holli K, Heikkinen M, Suonio E, Aro AR, Hietanen P, Huovinen R. Joensuu H, et al. J Clin Oncol. 1998 Dec;16(12):3720-30. doi: 10.1200/JCO.1998.16.12.3720. J Clin Oncol. 1998. PMID: 9850014 Clinical Trial.

10

Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.

Isokangas OP, Knuuttila A, Halme M, Mäntylä M, Lindström I, Nikkanen V, Viren M, Joensuu H, Mattson K. Isokangas OP, et al. Among authors: joensuu h. Ann Oncol. 1999 Sep;10(9):1059-63. doi: 10.1023/a:1008305017829. Ann Oncol. 1999. PMID: 10572603 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

610 results

Search Page